Proactive - Interviews for investors

Magnetite Mines Ltd (ASX:MGT) CEO Tim Dobson joins Proactive’s Tylah Tully to discuss its renounceable rights issue, offering eligible shareholders the opportunity to purchase one new share for every five held at a price of $0.20 per share.

This initiative aims to raise approximately $4.1 million before costs with funds intended to support the future development of the Razorback Iron Ore Project in South Australia, specifically targeting the completion of the project’s definitive feasibility study (DFS) and securing necessary Mining Lease approvals.

This rights issue follows a previous fundraising effort in July 2024, where the company raised $1.17 million from existing shareholders. Those shareholders are now eligible to receive one free option for every share purchased as a gesture of recognition for their support.

The company sees the importance of strengthening its balance sheet to attract strategic partners and secure regulatory approvals for the Razorback project.

#Proactiveinvestors #MagnetiteMines #ASX #RightsIssue #IronOre #MiningInvestment #RazorbackProject #Shareholders #CapitalRaising #FeasibilityStudy #MiningLease #StrategicPartnerships #JFEGroup #SteelIndustry #EquityMarkets #MiningFunding #ResourceDevelopment #AustralianMining #InvestorRelations #MiningNews #ProjectDevelopment #MiningOpportunities #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Synertec Corporation Ltd (ASX:SOP) managing director Michael Carroll and general manager of finance Yash Gala join Proactive’s Tylah Tully to discuss 2024 financial year results featuring a 26% increase in revenue and other income to $19.7 million.

This growth was primarily driven by the expansion of its engineering services and deployment of its Powerhouse micro-grid renewable energy and storage solution. The company successfully rolled out three Powerhouse units during the fiscal year, contributing $1.1 million to group revenue, and is currently engaging with 15 potential customers for future deployments.

The Powerhouse units demonstrated superior performance with more than 99.9% uptime and no need for site visits or maintenance. Synertec has also formed an exclusive partnership with Siemens to support further development and market expansion of the Powerhouse technology.

Since FY2021, Synertec’s revenue has increased 135%, reflecting the company’s expanding operational footprint and the growing contribution of Powerhouse technology through long-term contracts.

The company recently completed a capital restructure and secured its first debt facility, providing $21 million in working capital for FY25. Synertec’s management emphasized their focus on strategy execution and their commitment to delivering significant value for shareholders as the technology and engineering businesses reach critical growth stages.

Synertec is holding a webinar on Friday August 6 at 2pm to discuss its results and key achievements.

#Proactiveinvestors #Synertec #ASX #RevenueGrowth, #Powerhouse, #RenewableEnergy, #ASXNews, #EngineeringServices, #MicroGrid, #TechnologyDevelopment, #SiemensPartnership, #BusinessExpansion, #FinancialResults, #SustainableEnergy, #ShareholderValue, #DebtFacility, #StrategicGrowth #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to share its lead drug formulation, Ruvidar, has shown significant preclinical effectiveness in destroying the Herpes Simplex Virus 1 (HSV-1), surpassing the current standard of care, Acyclovir. Acyclovir, widely used to manage HSV-1, does not cure the virus but helps to alleviate symptoms associated with herpes infections, such as cold sores, genital herpes, shingles, and chicken pox.

DuMoulin-White highlighted that the global antiviral drug market is projected to reach around $71 billion by 2032, with approximately 3.7 billion people under age 50 infected with HSV-1. The preclinical findings indicate that Ruvidar is not only more potent than Acyclovir but also capable of preventing HSV-1 replication by an impressive 10 million-fold if administered one day post-infection—something Acyclovir fails to achieve.

These promising results position Ruvidar as a potential game-changer in the treatment of HSV-1, offering hope for more effective management of this widespread virus.

#proactiveinvestors #theralasetechnologiesinc #tsxv #tlt #otcqb #tftff #MedicalResearch #HealthcareInnovation #PatientCare #CancerResearch #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

#proactiveinvestors #theralasetechnologiesinc #tsxv #tlt #otcqb #tftff #MedicalResearch #HealthcareInnovation #PatientCare #CancerResearch #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #Ruvidar #Acyclovir #Pharmaceuticals #Biotech #Oncology #ViralInfections #DrugDevelopment #ProactiveInvestors

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Baylin Technologies CEO Leighton Carroll joined Steve Darling from Proactive to announce that the company's subsidiary, Advantech Wireless Technologies, has received significant orders totaling $2.25 million. These orders, placed by a major sports and entertainment satellite broadcaster and services provider, include C-Band and Ku-Band Solid State Power Block (SSPB) amplifiers.

Carroll highlighted that the C-Band portion of the order comprises Gallium Nitride-based Dakota SSPBs, which will be mounted on vehicles to enhance the broadcaster’s mobile network. Additionally, the high-power 500W Genesis-HP Ku-Band Block-Up Converters are slated for installation at the customer’s master teleport facility. Advantech’s products were selected for their resilient architecture and unique software capabilities, which meet the high demands of the broadcasting industry.

Carroll explained how these divisions are crucial for the company's growth, noting that their satellite communications technology supports major events like the NFL Super Bowl and the NASA Artemis lunar mission. He emphasized the importance of Baylin Technologies' unique intellectual property and how it differentiates the company in competitive markets.

Carroll also shared the company's financial performance for the second quarter of 2024. Baylin Technologies reported revenue of $22 million, marking an increase of $0.7 million or 3.4% compared to the same quarter in 2023. This also represents a substantial rise of $1.9 million or 9.9% from the first quarter of 2024. Furthermore, the company achieved an adjusted EBITDA of $2.3 million in Q2 2024, an impressive increase of $1.2 million or 116% compared to Q2 2023. This also reflects a significant growth of $1.8 million or 394% compared to the first quarter of 2024.

This recent success underscores Baylin Technologies' growing influence in the satellite communications market, driven by Advantech Wireless Technologies' cutting-edge solutions and strong market demand.

#proactiveinvestors #baylintechnologiesinc #tsx #byl

#LeightonCarroll #TechInnovation #SatelliteCommunications #WirelessInfrastructure #EmbeddedSystems #TechGrowth #CorporateStrategy #BusinessTurnaround #ProactiveInvestor

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

HeLIX Exploration PLC (AIM:HEX) CEO Bo Sears discusses the latest operational update on the Clink #1 well at the company's Ingomar Dome Project in Montana with Proactive's Stephen Gunnion.

Sears expressed excitement about the findings, particularly the significant showings of helium and hydrogen, which he described as "incredible." He highlighted that hydrogen grades have increased towards total depth, an "extremely positive signal" according to Sears.

However, the operation encountered a minor setback in the shallow section of the wellbore, specifically in the Mowry Shale, which is proving to be problematic. Despite this, Sears remains confident, explaining that the issue is manageable and that they are fully funded for continued operations, including future activities at the Rudyard appraisal well.

Don't miss out on this crucial update from Helix Exploration. Visit Proactive's YouTube channel for more in-depth videos, and don't forget to like, subscribe, and enable notifications for the latest updates.

#HelixExploration #BoSears #HydrogenDiscovery #HeliumExploration #IngomarDome #OilAndGas #EnergyExploration #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Oriole Resources PLC (AIM:ORR) CEO Martin Rosser talked with Proactive about the initial trenching results from the Mbe licence MB01-N sub-prospect, part of its phase one exploration program.

Rosser detailed significant findings from the first three trenches, including a highlight of 50 meters grading at 1.1 grams per tonne with a 20-meter zone at 2.2 grams per tonne in Trench One. Trench Three also yielded promising results with 68 meters grading at 0.77 grams per tonne.

Rosser emphasised the strong correlation between the previously reported soil anomalies and the trenching outcomes, noting that these results give the company a deeper understanding of the prospect's potential. However, he cautioned that while the trenching results are encouraging, they should not be directly extrapolated to depth due to grade depletion near the surface.

Looking ahead, Rosser discussed the next steps, including more trenching at the Mbe South Prospect, which he described as having a larger areal extent and more robust grade distribution. These upcoming results will guide the planning for the 2024-2025 drilling season.

Visit Proactive's YouTube channel for more videos, and don't forget to give this video a like, subscribe to the channel, and enable notifications for future content.

#OrioleResources #Mining #TrenchingResults #Exploration #GoldMining #MbeProspect #PhaseOneExploration #ResourceDevelopment #CEOInterview #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Los Andes Copper Ltd (TSX-V:LA) chairman Eduardo Covarrubias takes Proactive's Stephen Gunnion through the latest significant developments surrounding the company's Vizcachitas project and its role in the Desala Petorca water desalination project in Chile.

Covarrubias highlighted the importance of the project, which will supply water to various stakeholders in the Petorca Valley, including mining companies, agricultural producers, and local communities. He emphasized that Vizcachitas will be the anchor client for this project, which has announced a strategic alliance with major Chilean power company Colbún, making it crucial for the feasibility of the entire initiative.

Covarrubias also discussed the recent streamlining of the royalty agreement with Franco-Nevada Corporation, which is expected to simplify operations when Vizcachitas enters production. This agreement also brought in a $1.2 million interest-free payment, further strengthening the company’s balance sheet.

The conversation also touched on Los Andes Copper's ongoing efforts in community engagement, environmental approvals, and exploration activities aimed at expanding the Vizcachitas deposit. Covarrubias hinted at exciting news to come, particularly regarding the results of their geophysics and exploration work.

Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#LosAndesCopper #VizcachitasProject #ChileMining #Desalination #WaterSustainability #MiningUpdates #CopperMining #CommunityImpact #FrancoNevada #EnvironmentalApprovals

#proactiveinvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Andrada Mining Ltd CFO Hiten Ooka joined Proactive's Stephen Gunnion with more on the company's strong financial results and strategic initiatives in the past year. Ooka highlighted that Andrada Mining's revenue increased by over 80% due to ramped-up tin production at its flagship project. He also emphasised the company's progress in reducing costs and achieving key milestones in its tantalum and lithium strategies.

One of the major highlights was the commissioning of the lithium pilot plant and tantalum circuit, both of which have started production. The CFO also discussed securing various financing streams, including convertible loan notes and a package from Orion Finance, as well as the Development Bank of Namibia's contribution to continuous improvement projects.

Looking ahead, Ooka remains optimistic about the company's financial year 2025, noting the positive operational outlook and ongoing efforts to secure a strategic partner for the lithium operation.

Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#AndradaMining #CFOInterview #TinProduction #LithiumExpansion #TantalumCircuit #MiningFinance #StrategicGrowth #MiningIndustry #ProactiveInvestors #MiningNews #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Oncimmune Holdings PLC CEO Martin Gouldstone discusses the company's recent achievements, including a new $700,000 contract with a major pharmaceutical company. This contract follows a significant $1.5 million deal announced in May 2024. Gouldstone emphasised the growing commercial traction of Oncimmune's profiling autoantibodies technology, particularly in diseases affecting the immune system.

During the interview, Gouldstone discussed the company’s pipeline and the importance of these contracts as indicators of Oncimmune's progress. "Contracts like these give us a lot of confidence that we can meet our full year 2024 targets and achieve profitability in full year 2025," said Gouldstone. He also highlighted the company's strategy to expand its commercial team, particularly in the US market.

With these significant wins, Oncimmune is on track to reach profitability for the first time in its history, marking a major milestone for the company. Stay tuned to learn more about Oncimmune's ongoing developments and future announcements.

Visit Proactive’s YouTube channel for more videos, and don't forget to give this video a like, subscribe to the channel, and enable notifications for future content.

#Oncimmune #Pharmaceuticals #Autoantibodies #Biotech #HealthcareInnovation #MartinGouldstone #BiotechInvesting #CommercialStrategy #USMarket #ProactiveInvestors

#Oncimmune #Pharmaceuticals #Autoantibodies #Biotech #HealthcareInnovation #MartinGouldstone #BiotechInvesting #CommercialStrategy #USMarket #ProactiveInvestors

Roquefort Therapeutics PLC chief executive Ajan Reginald takes Proactive Stephen Gunnion through the significant progress the company has made over the summer, including advancing key programs and securing a European patent for its MK cell therapy.

Reginald highlighted the MK cell's unique ability to activate the body's natural killer cells, offering promising applications in both oncology and immunology. This patent covers 39 countries, protecting both the composition of the MK cells and their use in conjunction with natural killer cells.

Discussing the company’s next steps, Reginald pointed to the potential transformational impact of ongoing deals and the expansion of Roquefort’s immunology and oncology franchises.

"As mentioned in the RNS, it should be a transformational quarter for us," Reginald stated, reflecting the company’s strategic focus on developing and commercializing these cutting-edge therapies.

Stay tuned for more updates on Roquefort Therapeutics’ progress. Don’t forget to like the video, subscribe to our channel, and enable notifications for future content.

#RoquefortTherapeutics #Immunology #Oncology #MKCellTherapy #BiotechNews #CellTherapy #Pharmaceuticals #CancerResearch #PatentAward #InvestingInBiotech#proactiveinvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews